Earnings, Shipments, Revenue All Strong
Research In Motion isn't ready to say die yet! The handset maker reported a second-quarter loss of $0.27, much smaller than the $0.46 feared by analysts. Revenue of $2.9 billion beat the $2.5 billion consensus number and shipments beat estimates by 500,000 units. RIMM soars 14 percent before the bell on my tradeMONSTER platform.
Government Contract Lifts Cytori
Cytori Therapeutics announced that the U.S. Department of Health & Human Services awarded the company a $106 million contract to develop a therapy for treating burns. CYTX rallies 19 percent on the news.
Finish Line Beats the Street
Finish Line earned $0.49 a share in the second quarter on revenue of $385 million, beating the estimates of $0.44 and $358 million. Same-store sales rose more than 12 percent and the company also raised guidance after announcing it had become Macy's exclusive partner for athletic shoes. FINL climbs by 6 percent in early trading.
Another Strong Quarter From AZZ
AZZ reported profit $0.62, while analysts had only expected $0.52. Revenue exceeded $153 million, also better than the Street's $146 million estimate. Management raised guidance, as well, sending AZZ higher by 16 percent in the premarket.